China Pharma Holdings (CPHI) Shares Outstanding (2011 - 2026)

China Pharma Holdings (CPHI) has reported Shares Outstanding (Entity) for 17 consecutive years, with $40.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 1142.24% year-over-year to $40.5 million; the trailing twelve-month figure through Jun 2026 stood at $40.5 million (up 1142.24% YoY), and the FY2025 full-year result was $4.3 million, up 145.73% from the prior year.
• Shares Outstanding (Entity) advanced to $40.5 million in Q2 2026 per CPHI's latest filing, from $25.6 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $40.5 million in Q2 2026 and bottomed at $96600.0 in Q1 2022.
• Historically, Shares Outstanding (Entity) has averaged $4.9 million across 5 years, with a median of $1.6 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) advanced 6.57% in 2022, then jumped 1142.24% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $105137.0 in 2022, then soared by 221.82% to $338357.0 in 2023, then surged by 416.13% to $1.7 million in 2024, then jumped by 145.73% to $4.3 million in 2025, then soared by 844.25% to $40.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $40.5 million, $25.6 million, and $4.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.